OraSure Technologies, Inc. (OSUR)
USD 3.79
(-2.07%)
USD 3.79
(-2.07%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 179.42 Million USD | 21.53% |
| 2022 | 147.63 Million USD | 25.54% |
| 2021 | 117.6 Million USD | 15.44% |
| 2020 | 101.86 Million USD | 7.7% |
| 2019 | 94.58 Million USD | -16.75% |
| 2018 | 113.61 Million USD | 14.81% |
| 2017 | 98.95 Million USD | 12.42% |
| 2016 | 88.02 Million USD | 9.63% |
| 2015 | 80.29 Million USD | 20.52% |
| 2014 | 66.62 Million USD | 13.71% |
| 2013 | 58.58 Million USD | 5.43% |
| 2012 | 55.57 Million USD | 7.45% |
| 2011 | 51.71 Million USD | 9.2% |
| 2010 | 47.35 Million USD | 0.49% |
| 2009 | 47.13 Million USD | 14.59% |
| 2008 | 41.12 Million USD | -18.21% |
| 2007 | 50.28 Million USD | 15.86% |
| 2006 | 43.39 Million USD | 4.85% |
| 2005 | 41.39 Million USD | 29.9% |
| 2004 | 31.86 Million USD | 30.65% |
| 2003 | 24.38 Million USD | 27.55% |
| 2002 | 19.12 Million USD | -5.53% |
| 2001 | 20.23 Million USD | -4.08% |
| 2000 | 21.1 Million USD | 201.45% |
| 1999 | 7 Million USD | 2.94% |
| 1998 | 6.8 Million USD | 3.03% |
| 1997 | 6.6 Million USD | -34.65% |
| 1996 | 10.1 Million USD | 10000.0% |
| 1995 | 100 Thousand USD | 112.5% |
| 1994 | -800 Thousand USD | -150.0% |
| 1993 | 1.6 Million USD | -11.11% |
| 1992 | 1.8 Million USD | -5.26% |
| 1991 | 1.9 Million USD | 18.75% |
| 1990 | 1.6 Million USD | 260.0% |
| 1989 | -1 Million USD | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q1 | 24.29 Million USD | -31.83% |
| 2024 Q2 | 25.57 Million USD | 5.28% |
| 2023 FY | 179.42 Million USD | 21.53% |
| 2023 Q4 | 35.64 Million USD | -19.62% |
| 2023 Q2 | 26.37 Million USD | -59.93% |
| 2023 Q1 | 65.81 Million USD | 32.72% |
| 2023 Q3 | 44.34 Million USD | 68.14% |
| 2022 Q4 | 49.58 Million USD | 7.35% |
| 2022 Q1 | 24.27 Million USD | -10.54% |
| 2022 Q2 | 27.58 Million USD | 13.65% |
| 2022 FY | 147.63 Million USD | 25.54% |
| 2022 Q3 | 46.19 Million USD | 67.46% |
| 2021 Q2 | 30.67 Million USD | -19.97% |
| 2021 Q3 | 21.46 Million USD | -30.01% |
| 2021 Q1 | 38.32 Million USD | 0.37% |
| 2021 Q4 | 27.13 Million USD | 26.39% |
| 2021 FY | 117.6 Million USD | 15.44% |
| 2020 Q1 | 16.13 Million USD | -45.94% |
| 2020 FY | 101.86 Million USD | 7.7% |
| 2020 Q2 | 17.26 Million USD | 7.02% |
| 2020 Q3 | 30.28 Million USD | 75.45% |
| 2020 Q4 | 38.18 Million USD | 26.07% |
| 2019 FY | 94.58 Million USD | -16.75% |
| 2019 Q4 | 29.83 Million USD | 37.85% |
| 2019 Q1 | 18.08 Million USD | -47.91% |
| 2019 Q3 | 21.64 Million USD | -13.48% |
| 2019 Q2 | 25.01 Million USD | 38.37% |
| 2018 Q2 | 25.89 Million USD | 5.84% |
| 2018 FY | 113.61 Million USD | 14.81% |
| 2018 Q3 | 28.54 Million USD | 10.23% |
| 2018 Q4 | 34.7 Million USD | 21.58% |
| 2018 Q1 | 24.46 Million USD | -14.23% |
| 2017 Q2 | 25.47 Million USD | 25.44% |
| 2017 FY | 98.95 Million USD | 12.42% |
| 2017 Q4 | 28.52 Million USD | 15.75% |
| 2017 Q3 | 24.64 Million USD | -3.27% |
| 2017 Q1 | 20.31 Million USD | -15.21% |
| 2016 Q1 | 20.31 Million USD | -7.37% |
| 2016 Q2 | 21.08 Million USD | 3.8% |
| 2016 FY | 88.02 Million USD | 9.63% |
| 2016 Q3 | 22.67 Million USD | 7.54% |
| 2016 Q4 | 23.95 Million USD | 5.64% |
| 2015 FY | 80.29 Million USD | 20.52% |
| 2015 Q4 | 21.93 Million USD | 6.1% |
| 2015 Q3 | 20.66 Million USD | -0.13% |
| 2015 Q1 | 16.99 Million USD | -5.45% |
| 2015 Q2 | 20.69 Million USD | 21.76% |
| 2014 FY | 66.62 Million USD | 13.71% |
| 2014 Q1 | 13.92 Million USD | -18.69% |
| 2014 Q4 | 17.97 Million USD | -3.89% |
| 2014 Q3 | 18.7 Million USD | 16.79% |
| 2014 Q2 | 16.01 Million USD | 15.0% |
| 2013 Q4 | 17.12 Million USD | 14.7% |
| 2013 Q3 | 14.93 Million USD | 2.99% |
| 2013 Q2 | 14.49 Million USD | 20.53% |
| 2013 FY | 58.58 Million USD | 5.43% |
| 2013 Q1 | 12.02 Million USD | -9.22% |
| 2012 Q4 | 13.25 Million USD | -4.59% |
| 2012 Q3 | 13.88 Million USD | -5.52% |
| 2012 Q2 | 14.69 Million USD | 7.04% |
| 2012 Q1 | 13.73 Million USD | -5.92% |
| 2012 FY | 55.57 Million USD | 7.45% |
| 2011 Q3 | 13.59 Million USD | 10.87% |
| 2011 FY | 51.71 Million USD | 9.2% |
| 2011 Q4 | 14.59 Million USD | 7.37% |
| 2011 Q2 | 12.26 Million USD | 8.82% |
| 2011 Q1 | 11.26 Million USD | -5.83% |
| 2010 Q4 | 11.96 Million USD | 1.27% |
| 2010 FY | 47.35 Million USD | 0.49% |
| 2010 Q1 | 11.4 Million USD | -7.84% |
| 2010 Q2 | 12.17 Million USD | 6.79% |
| 2010 Q3 | 11.81 Million USD | -2.99% |
| 2009 Q1 | 10.97 Million USD | 13.98% |
| 2009 FY | 47.13 Million USD | 14.59% |
| 2009 Q2 | 9.87 Million USD | -9.95% |
| 2009 Q4 | 12.37 Million USD | -11.0% |
| 2009 Q3 | 13.9 Million USD | 40.73% |
| 2008 Q3 | 9.71 Million USD | -12.81% |
| 2008 FY | 41.12 Million USD | -18.21% |
| 2008 Q1 | 10.64 Million USD | -7.68% |
| 2008 Q2 | 11.14 Million USD | 4.7% |
| 2008 Q4 | 9.62 Million USD | -0.91% |
| 2007 Q1 | 12.52 Million USD | 8.97% |
| 2007 FY | 50.28 Million USD | 15.86% |
| 2007 Q2 | 13.46 Million USD | 7.49% |
| 2007 Q4 | 11.52 Million USD | -9.71% |
| 2007 Q3 | 12.76 Million USD | -5.16% |
| 2006 Q4 | 11.49 Million USD | 1.95% |
| 2006 FY | 43.39 Million USD | 4.85% |
| 2006 Q2 | 11.03 Million USD | 14.92% |
| 2006 Q3 | 11.27 Million USD | 2.2% |
| 2006 Q1 | 9.59 Million USD | -11.36% |
| 2005 Q2 | 9.46 Million USD | 0.03% |
| 2005 FY | 41.39 Million USD | 29.9% |
| 2005 Q4 | 10.83 Million USD | -7.0% |
| 2005 Q3 | 11.64 Million USD | 23.09% |
| 2005 Q1 | 9.45 Million USD | 11.23% |
| 2004 FY | 31.86 Million USD | 30.65% |
| 2004 Q4 | 8.5 Million USD | 0.57% |
| 2004 Q3 | 8.45 Million USD | 9.94% |
| 2004 Q2 | 7.68 Million USD | 6.54% |
| 2004 Q1 | 7.21 Million USD | -0.06% |
| 2003 Q2 | 5.8 Million USD | 15.45% |
| 2003 Q1 | 5.03 Million USD | 4.73% |
| 2003 Q3 | 6.32 Million USD | 8.97% |
| 2003 Q4 | 7.22 Million USD | 14.11% |
| 2003 FY | 24.38 Million USD | 27.55% |
| 2002 FY | 19.12 Million USD | -5.53% |
| 2002 Q4 | 4.8 Million USD | 0.97% |
| 2002 Q2 | 4.72 Million USD | -2.1% |
| 2002 Q1 | 4.83 Million USD | 12.12% |
| 2002 Q3 | 4.75 Million USD | 0.58% |
| 2001 Q4 | 4.3 Million USD | -24.75% |
| 2001 Q1 | 4.71 Million USD | -33.51% |
| 2001 Q3 | 5.72 Million USD | 4.21% |
| 2001 Q2 | 5.49 Million USD | 16.65% |
| 2001 FY | 20.23 Million USD | -4.08% |
| 2000 FY | 21.1 Million USD | 201.45% |
| 2000 Q4 | 7.08 Million USD | 44.44% |
| 2000 Q3 | 4.9 Million USD | 183.91% |
| 2000 Q2 | 1.72 Million USD | 6.75% |
| 2000 Q1 | 1.61 Million USD | 20.5% |
| 1999 FY | 7 Million USD | 2.94% |
| 1999 Q4 | 1.34 Million USD | -36.04% |
| 1999 Q3 | 2.1 Million USD | 5.0% |
| 1999 Q2 | 2 Million USD | 33.33% |
| 1999 Q1 | 1.5 Million USD | 7.14% |
| 1998 Q3 | 2.3 Million USD | 9.52% |
| 1998 FY | 6.8 Million USD | 3.03% |
| 1998 Q1 | 1.3 Million USD | 18.18% |
| 1998 Q2 | 2.1 Million USD | 61.54% |
| 1998 Q4 | 1.4 Million USD | -39.13% |
| 1997 FY | 6.6 Million USD | -34.65% |
| 1997 Q4 | 1.1 Million USD | 120.0% |
| 1997 Q3 | 500 Thousand USD | -77.27% |
| 1997 Q2 | 2.2 Million USD | 10.0% |
| 1997 Q1 | 2 Million USD | -51.22% |
| 1996 FY | 10.1 Million USD | 10000.0% |
| 1996 Q4 | 4.1 Million USD | -40.58% |
| 1996 Q3 | 6.9 Million USD | 666.67% |
| 1996 Q2 | 900 Thousand USD | -18.18% |
| 1996 Q1 | 1.1 Million USD | 0.0% |
| 1995 Q3 | - USD | -100.0% |
| 1995 Q2 | 300 Thousand USD | 400.0% |
| 1995 Q1 | -100 Thousand USD | 66.67% |
| 1995 FY | 100 Thousand USD | 112.5% |
| 1995 Q4 | 1.1 Million USD | 0.0% |
| 1994 FY | -800 Thousand USD | -150.0% |
| 1994 Q4 | -300 Thousand USD | 40.0% |
| 1994 Q3 | -500 Thousand USD | -400.0% |
| 1994 Q2 | -100 Thousand USD | 83.33% |
| 1994 Q1 | -600 Thousand USD | -220.0% |
| 1993 Q1 | 400 Thousand USD | 33.33% |
| 1993 FY | 1.6 Million USD | -11.11% |
| 1993 Q2 | 500 Thousand USD | 25.0% |
| 1993 Q3 | 400 Thousand USD | -20.0% |
| 1993 Q4 | 500 Thousand USD | 25.0% |
| 1992 Q4 | 300 Thousand USD | -50.0% |
| 1992 Q2 | 600 Thousand USD | 100.0% |
| 1992 Q3 | 600 Thousand USD | 0.0% |
| 1992 FY | 1.8 Million USD | -5.26% |
| 1992 Q1 | 300 Thousand USD | 0.0% |
| 1991 FY | 1.9 Million USD | 18.75% |
| 1991 Q1 | 300 Thousand USD | -50.0% |
| 1991 Q2 | 700 Thousand USD | 133.33% |
| 1991 Q3 | 200 Thousand USD | -71.43% |
| 1991 Q4 | 300 Thousand USD | 50.0% |
| 1990 Q3 | 300 Thousand USD | 0.0% |
| 1990 FY | 1.6 Million USD | 260.0% |
| 1990 Q1 | 400 Thousand USD | 0.0% |
| 1990 Q2 | 300 Thousand USD | -25.0% |
| 1990 Q4 | 600 Thousand USD | 100.0% |
| 1989 Q2 | 600 Thousand USD | -25.0% |
| 1989 FY | -1 Million USD | 0.0% |
| 1989 Q1 | 800 Thousand USD | 166.67% |
| 1989 Q4 | 400 Thousand USD | 116.0% |
| 1989 Q3 | -2.5 Million USD | -516.67% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Akoya Biosciences, Inc. | 56.3 Million USD | -218.659% |
| AngioDynamics, Inc. | 154.69 Million USD | -15.981% |
| AtriCure, Inc. | 300.37 Million USD | 40.267% |
| Avinger, Inc. | 2 Million USD | -8857.614% |
| Azenta, Inc. | 263.14 Million USD | 31.815% |
| BioLife Solutions, Inc. | 46.75 Million USD | -283.772% |
| The Cooper Companies, Inc. | 2.35 Billion USD | 92.391% |
| Daxor Corporation | 1.1 Million USD | -16160.15% |
| Ekso Bionics Holdings, Inc. | 9.07 Million USD | -1876.22% |
| Femasys Inc. | 691.9 Thousand USD | -25831.6% |
| GlucoTrack, Inc. | -13 Thousand USD | 1380261.538% |
| Harvard Bioscience, Inc. | 60.86 Million USD | -194.78% |
| Hologic, Inc. | 2.22 Billion USD | 91.946% |
| ICU Medical, Inc. | 739.87 Million USD | 75.75% |
| Intuitive Surgical, Inc. | 4.72 Billion USD | 96.206% |
| KORU Medical Systems, Inc. | 16.7 Million USD | -973.845% |
| LeMaitre Vascular, Inc. | 127.04 Million USD | -41.222% |
| Innovative Eyewear, Inc. | -119.32 Thousand USD | 150458.253% |
| Innovative Eyewear, Inc. | -119.32 Thousand USD | 150458.253% |
| Masimo Corporation | 1 Billion USD | 82.12% |
| Microbot Medical Inc. | -106 Thousand USD | 169365.094% |
| Meihua International Medical Technologies Co., Ltd. | 33.09 Million USD | -442.139% |
| Merit Medical Systems, Inc. | 583.87 Million USD | 69.27% |
| Nephros, Inc. | 8.4 Million USD | -2034.694% |
| NovoCure Limited | 381.05 Million USD | 52.915% |
| NEXGEL, Inc. | 619 Thousand USD | -28885.622% |
| NEXGEL, Inc. | 619 Thousand USD | -28885.622% |
| Singular Genomics Systems, Inc. | -558 Thousand USD | 32254.301% |
| Pro-Dex, Inc. | 14.55 Million USD | -1133.049% |
| Pulse Biosciences, Inc. | -1.2 Million USD | 14965.037% |
| Predictive Oncology Inc. | 1.14 Million USD | -15565.893% |
| Precision Optics Corporation, Inc. | 5.79 Million USD | -2994.652% |
| QuidelOrtho Corporation | 1.49 Billion USD | 87.994% |
| Repligen Corporation | 315.22 Million USD | 43.082% |
| Sanara MedTech Inc. | 57.13 Million USD | -214.018% |
| STAAR Surgical Company | 252.65 Million USD | 28.985% |
| Sharps Technology, Inc. | -891.24 Thousand USD | 20231.434% |
| Utah Medical Products, Inc. | 30.03 Million USD | -497.313% |
| DENTSPLY SIRONA Inc. | 2.08 Billion USD | 91.399% |
| Jin Medical International Ltd. | 6.78 Million USD | -2544.442% |